These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14978760)

  • 21. Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes.
    von Herrath MG; Efrat S; Oldstone MB; Horwitz MS
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9808-13. PubMed ID: 9275207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.
    Yun CO; Kim E; Koo T; Kim H; Lee YS; Kim JH
    Cancer Gene Ther; 2005 Jan; 12(1):61-71. PubMed ID: 15375379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of PEGylated adenovirus vector with targeting ligand.
    Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
    Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune evasion by adenovirus E3 proteins: exploitation of intracellular trafficking pathways.
    Windheim M; Hilgendorf A; Burgert HG
    Curr Top Microbiol Immunol; 2004; 273():29-85. PubMed ID: 14674598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of adenovirus E3-11.6K protein induces cell killing by both caspase-dependent and caspase-independent mechanisms.
    Zou A; Atencio I; Huang WM; Horn M; Ramachandra M
    Virology; 2004 Sep; 326(2):240-9. PubMed ID: 15302210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelium has a local anti-adenovirus vector system and glucocorticoid optimizes its gene transduction.
    Murata T; Hori M; Lee S; Nakamura A; Kohama K; Karaki H; Ozaki H
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1796-803. PubMed ID: 15961702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice.
    Varnavski AN; Calcedo R; Bove M; Gao G; Wilson JM
    Gene Ther; 2005 Mar; 12(5):427-36. PubMed ID: 15647774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus E3-19K proteins of different serotypes and subgroups have similar, yet distinct, immunomodulatory functions toward major histocompatibility class I molecules.
    Fu J; Li L; Bouvier M
    J Biol Chem; 2011 May; 286(20):17631-9. PubMed ID: 21454588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.
    Ilan Y; Droguett G; Chowdhury NR; Li Y; Sengupta K; Thummala NR; Davidson A; Chowdhury JR; Horwitz MS
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2587-92. PubMed ID: 9122239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-suppressive activities by chemokines introduced into OV-HM cells using fiber-mutant adenovirus vectors.
    Gao JQ; Alexandre LS; Tsuda Y; Katayama K; Eto Y; Sekiguchi F; Mizuguchi H; Hayakawa T; Nakayama T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
    Pharmazie; 2004 Mar; 59(3):238-9. PubMed ID: 15074605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI.
    Grant JR; Moise AR; Jefferies WA
    Clin Vaccine Immunol; 2007 Jul; 14(7):907-17. PubMed ID: 17538121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity.
    Barton KN; Paielli D; Zhang Y; Koul S; Brown SL; Lu M; Seely J; Kim JH; Freytag SO
    Mol Ther; 2006 Feb; 13(2):347-56. PubMed ID: 16290236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.
    Schagen FH; Ossevoort M; Toes RE; Hoeben RC
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):51-70. PubMed ID: 15094159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.
    Bernt KM; Ni S; Tieu AT; Lieber A
    Cancer Res; 2005 May; 65(10):4343-52. PubMed ID: 15899826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
    Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
    Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells.
    Hartman ZC; Black EP; Amalfitano A
    Virology; 2007 Feb; 358(2):357-72. PubMed ID: 17027060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive and negative regulation of adenovirus infection by CAR-like soluble protein, CLSP.
    Kawabata K; Tashiro K; Sakurai F; Osada N; Kusuda J; Hayakawa T; Yamanishi K; Mizuguchi H
    Gene Ther; 2007 Aug; 14(16):1199-207. PubMed ID: 17538635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of adenovirus fiber structure and function on vector development for gene therapy.
    Nicklin SA; Wu E; Nemerow GR; Baker AH
    Mol Ther; 2005 Sep; 12(3):384-93. PubMed ID: 15993650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model systems for studying the effects of adenovirus E3 genes on virulence in vivo.
    Horwitz MS; Tufariello J; Grunhaus A; Fejer G
    Curr Top Microbiol Immunol; 1995; 199 ( Pt 3)():195-211. PubMed ID: 7555077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.